| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/04/2008 | WO2008073893A3 Methods for producing an adenovirus type 5 gene transfer vector |
| 12/04/2008 | WO2008073154A3 Methods and compositions for treating disease |
| 12/04/2008 | WO2008070273A3 Methods of expressing lim mineralization protein |
| 12/04/2008 | WO2008067373A3 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 12/04/2008 | WO2008066658A3 Engineered cellular pathways for programmed autoregulation of differentiation |
| 12/04/2008 | WO2008060478A3 Hedgehog signaling pathway proteins and uses thereof |
| 12/04/2008 | WO2008029276A3 Compositions and methods for the treatment of ophthalmic disease |
| 12/04/2008 | WO2008008365A3 Biocompatible hydrogels |
| 12/04/2008 | WO2008005769A3 Methods of inhibiting hcv replication |
| 12/04/2008 | WO2007136910A3 Eimmunotherapy for immune suppressed patients |
| 12/04/2008 | WO2007127882A3 An isolated dna fragment of the human a33 promoter and its use to control the expression of a heterologous gene in tumor cells |
| 12/04/2008 | WO2007124478A3 Method and system for preparing soft tissue for grafting, enhancing grafting results, and grafting autologous fat and adipocyte derived stem cells to soft tissue such as the breast and other tissue defects |
| 12/04/2008 | WO2006073625A3 Inhibition of li expression in mammalian cells |
| 12/04/2008 | US20080301826 Novel beta-actin and rps21 promoters and uses thereof |
| 12/04/2008 | US20080300395 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents |
| 12/04/2008 | US20080300384 T-bet compositions and methods of use thereof |
| 12/04/2008 | US20080300183 Gastrointestinal proliferative factor and uses thereof |
| 12/04/2008 | US20080299642 Vectors with modified protease-dependent tropism |
| 12/04/2008 | US20080299547 Novel stra6 polypeptides |
| 12/04/2008 | US20080299536 Material and Methods for Nerve Grafting |
| 12/04/2008 | US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/04/2008 | US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using |
| 12/04/2008 | US20080299093 Premixed biological hydraulic cement paste composition and using the same |
| 12/04/2008 | US20080299083 Adenoviral vectors having a protein IX deletion |
| 12/04/2008 | US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene |
| 12/04/2008 | DE102007025107A1 Arzneimittel zur Behandlung von Fertilitäts- und Schwangerschaftsstörungen und immunologisch-bedingten Erkrankungen und Transplantationen zur Anwendung in der Tiermedizin, insbesondere bei Pferden sowie Verfahren zur Herstellung Medicines used to treat fertility and pregnancy disorders and immunologically-related disorders and transplantation for use in veterinary medicine, particularly in horses and methods of making |
| 12/03/2008 | EP1998177A2 Compositions and methods for diagnosing and treating colon cancers |
| 12/03/2008 | EP1997900A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 12/03/2008 | EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications |
| 12/03/2008 | EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 12/03/2008 | EP1997890A1 Chinese hamster apoptosis-related genes |
| 12/03/2008 | EP1996713A2 Use of pol iii promoters for controlled expression of therapeutic proteins |
| 12/03/2008 | EP1996619A2 Gpcrs as angiogenesis targets |
| 12/03/2008 | EP1996238A2 Chimeric adenoviral vectors |
| 12/03/2008 | EP1575354B1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure, and applications thereof |
| 12/03/2008 | EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof |
| 12/03/2008 | EP1121140B1 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 12/03/2008 | EP1097233B1 Growth differentiation factor promoter and uses therefor |
| 12/03/2008 | EP1083968A4 FLOW-THROUGH ELECTROPORATION SYSTEM FOR $i(EX VIVO) GENE THERAPY |
| 12/03/2008 | CN101316611A Induction of mucosal tolerance to antigens |
| 12/03/2008 | CN101314794A Method for detecting oral squamous-cell carcinoma and method for suppressing the same |
| 12/03/2008 | CN101314793A Method for detecting ovarian cancer and method for suppresssing the same |
| 12/03/2008 | CN101314777A Amalgamation gene and prepared vaccine |
| 12/03/2008 | CN101314775A RNA disturbance target point capable of being used for treating AIDS |
| 12/03/2008 | CN101314615A Viral capsid mosaic protein HPV16 L1-P<D>, preparation method and application thereof |
| 12/03/2008 | CN101314047A Method and medicament for treating viral infection |
| 12/03/2008 | CN100439498C Small interference RNA of sinalbin myroxin receptor mIL17RE gene its coding gene and application thereof |
| 12/03/2008 | CN100439497C Purification method adapted to mass production of plasmid DNA |
| 12/03/2008 | CN100439493C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 12/03/2008 | CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer |
| 12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
| 12/03/2008 | CN100438920C Cancer gene therapeutic drug |
| 12/03/2008 | CN100438919C Nucleic acid vaccine, and its application |
| 12/03/2008 | CN100438918C Vaccine against SARS virogene and its preparation method and use |
| 12/03/2008 | CN100438909C 化合物 Compound |
| 12/03/2008 | CN100438908C CpG formulations and related methods |
| 12/03/2008 | CN100438907C Bacterin of tabling gene of E type hepatitis virus |
| 12/02/2008 | US7459547 Determination competitive binder between Rna and target compound in plants |
| 12/02/2008 | US7459541 Fusion polypeptide comprising a collagen-binding domain and an epithelial cell proliferation-modulating domain for use as tool in regenerative medicine and tissue repair |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459534 Inactivation resistant factor VIII |
| 12/02/2008 | US7459531 Glycosylated polypeptide of given amino acid sequence; treatment of genetic diseases such as muscular dystrophy and cystic fibrosis |
| 12/02/2008 | US7459524 Polypeptide of given sequence; use in vaccines |
| 12/02/2008 | US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders |
| 12/02/2008 | US7459291 Chordin-like molecules and uses thereof |
| 12/02/2008 | US7459282 Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer |
| 12/02/2008 | US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 12/02/2008 | US7459163 Infectious DNA as a vaccine against west nile and other flaviviruses |
| 12/02/2008 | US7459154 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 12/02/2008 | US7459153 Viral vectors for gene therapy |
| 12/02/2008 | CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide |
| 12/02/2008 | CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/02/2008 | CA2100268C Method for culturing and transforming human stem cell-containing compositions |
| 12/01/2008 | CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof |
| 11/27/2008 | WO2008144754A2 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases |
| 11/27/2008 | WO2008144591A2 Treatment of synucleinopathies |
| 11/27/2008 | WO2008144508A2 Modulating mhc class ii antigen presentation in dendritic cells prevents diabetes |
| 11/27/2008 | WO2008144506A1 Apoptotic pathway targeting for the diagnosis and treatment of cancer |
| 11/27/2008 | WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 11/27/2008 | WO2008144058A1 Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin |
| 11/27/2008 | WO2008143875A1 Targeted delivery of glycine receptors to excitable cells |
| 11/27/2008 | WO2008143354A1 Pharmaceutical composition for enzyme replacement therapy |
| 11/27/2008 | WO2008142162A2 Pharmaceutical agent for the treatment of fertility and gestation disorders, immunological diseases, and transplantation for use in veterinary medicine, particularly in horses, and methods for the production and treatment monitoring thereof |
| 11/27/2008 | WO2008141438A1 Gabaergic modulators for treating airway conditions |
| 11/27/2008 | WO2008110624A3 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors |
| 11/27/2008 | WO2008106658A3 TRIGGERED RNAi |
| 11/27/2008 | WO2008088582A3 Methods and materials related to trail isoforms |
| 11/27/2008 | WO2008060557A3 Efficient nuclear delivery of antisense oligonucleotides |
| 11/27/2008 | WO2008036916A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 11/27/2008 | WO2008033393A3 Isolation, expansion and uses of tumor stem cells |
| 11/27/2008 | WO2007100908A3 Chimeric adenoviral vectors |
| 11/27/2008 | US20080295192 Self-induced deletion of dna |
| 11/27/2008 | US20080293829 Novel Compounds |
| 11/27/2008 | US20080293663 Cellular genes regulated by hiv-1 infection and methods of use thereof |
| 11/27/2008 | US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 11/27/2008 | US20080293659 FC gamma RIIA-specific nucleic acid interference |
| 11/27/2008 | US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 11/27/2008 | US20080293657 Modulation of the expression of stat-1-dependent genes |
| 11/27/2008 | US20080293652 Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours |
| 11/27/2008 | US20080293628 Methods and Compositions for the Inhibition of Thrombus Formation |